224 related articles for article (PubMed ID: 31048016)
1. Novel half-sandwich rhodium(III) and iridium(III) photosensitizers for dual chemo- and photodynamic therapy.
Su W; Luo Z; Dong S; Chen X; Xiao JA; Peng B; Li P
Photodiagnosis Photodyn Ther; 2019 Jun; 26():448-454. PubMed ID: 31048016
[TBL] [Abstract][Full Text] [Related]
2. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and photodynamic activity of half-sandwich rhodium(III) complexes with curcuminoids.
Zhang B; Xiao J; Wang X; Li P; Su W
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102049. PubMed ID: 33059109
[TBL] [Abstract][Full Text] [Related]
4. Ir(III) Half-Sandwich Photosensitizers with a π-Expansive Ligand for Efficient Anticancer Photodynamic Therapy.
Gonzalo-Navarro C; Zafon E; Organero JA; Jalón FA; Lima JC; Espino G; Rodríguez AM; Santos L; Moro AJ; Barrabés S; Castro J; Camacho-Aguayo J; Massaguer A; Manzano BR; Durá G
J Med Chem; 2024 Feb; 67(3):1783-1811. PubMed ID: 38291666
[TBL] [Abstract][Full Text] [Related]
5. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
Qin WW; Pan ZY; Cai DH; Li Y; He L
Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
[TBL] [Abstract][Full Text] [Related]
6. Organometallic rhodium(III) and iridium(III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands.
Pettinari R; Marchetti F; Pettinari C; Condello F; Petrini A; Scopelliti R; Riedel T; Dyson PJ
Dalton Trans; 2015 Dec; 44(47):20523-31. PubMed ID: 26548708
[TBL] [Abstract][Full Text] [Related]
7. Rhodium Nanoparticles as a Novel Photosensitizing Agent in Photodynamic Therapy against Cancer.
Machuca A; Garcia-Calvo E; Anunciação DS; Luque-Garcia JL
Chemistry; 2020 Jun; 26(34):7685-7691. PubMed ID: 32294275
[TBL] [Abstract][Full Text] [Related]
8. The discovery of half-sandwich iridium complexes containing lidocaine and (pyren-1-yl)ethynyl derivatives of phenylcyanamide ligands for photodynamic therapy.
Tabrizi L
Dalton Trans; 2017 Jun; 46(22):7242-7252. PubMed ID: 28534895
[TBL] [Abstract][Full Text] [Related]
9. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
10. Bioactive half-sandwich Rh and Ir bipyridyl complexes containing artemisinin.
Chellan P; Avery VM; Duffy S; Land KM; Tam CC; Kim JH; Cheng LW; Romero-Canelón I; Sadler PJ
J Inorg Biochem; 2021 Jun; 219():111408. PubMed ID: 33826972
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy.
Huang H; Banerjee S; Sadler PJ
Chembiochem; 2018 Aug; 19(15):1574-1589. PubMed ID: 30019476
[TBL] [Abstract][Full Text] [Related]
12. Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp
Guo L; Li P; Li J; Gong Y; Li X; Liu Y; Yu K; Liu Z
Inorg Chem; 2023 Sep; 62(37):15118-15137. PubMed ID: 37671819
[TBL] [Abstract][Full Text] [Related]
13. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Study on Ir
Kowalik M; Masternak J; Olszewski M; Maciejewska N; Kazimierczuk K; Sitkowski J; Dąbrowska AM; Chylewska A; Makowski M
Inorg Chem; 2024 Jan; 63(2):1296-1316. PubMed ID: 38174357
[TBL] [Abstract][Full Text] [Related]
15. Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)
Rubio AR; Fidalgo J; Martin-Vargas J; Pérez-Arnaiz C; Alonso-Torre SR; Biver T; Espino G; Busto N; García B
J Inorg Biochem; 2020 Feb; 203():110885. PubMed ID: 31731049
[TBL] [Abstract][Full Text] [Related]
16. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
17. Dipyrrinato-Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation.
Hohlfeld BF; Gitter B; Kingsbury CJ; Flanagan KJ; Steen D; Wieland GD; Kulak N; Senge MO; Wiehe A
Chemistry; 2021 Apr; 27(21):6440-6459. PubMed ID: 33236800
[TBL] [Abstract][Full Text] [Related]
18. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
19. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
[TBL] [Abstract][Full Text] [Related]
20. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
